| Outcome Measures: |
Primary: 3-point MACE, Number of 3-point MACE events defined as non-fatal MI, non-fatal stroke, and mortality, 1/1/2014 - 12/31/2021 | Secondary: Expanded MACE and its components, Number of 3-point MACE (non-fatal MI, non-fatal stroke, mortality) plus heart failure hospitalization and revascularization procedure events, 1/1/2014 - 12/31/2021|Non-fatal myocardial infarction (MI), Number of non-fatal myocardial infarctions, 1/1/2014 - 12/31/2021|Non-fatal stroke events, Number of non-fatal stroke events, 1/1/2014 - 12/31/2021|All-cause moratality, Number of deaths, 1/1/2014 - 12/31/2021|Severe hypoglycemia, Number of emergency department visits or hospitalization for hypoglycemia, 1/1/2014 - 12/31/2021|Incident end-stage kidney disease, Number of initiation of dialysis or new diagnosis of stage 5 or end-stage kidney disease, 1/1/2014 - 12/31/2021|Treatment for diabetic retinopathy or macular edema, Number of treatments for diabetic retinopathy or macular edema, 1/1/2014 - 12/31/2021|Lower extremity complications, Number of foot and/or leg amputation, osteomyelitis, ulcer, Charcot arthropathy, 1/1/2014 - 12/31/2021
|
